Acetaminophen-related Hepatotoxicity

Clinics in Liver Disease

Volumn 17, Issue 4, 2013, Pages 587-607

  Bunchorntavakul, Chalermrat ^a,b   Reddy, K Rajender ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b RANGSIT UNIVERSITY   (Thailand)

Author keywords

Acetaminophen; Acute liver failure; Drug induced liver injury; Hepatotoxicity; Liver transplantation; N acetylcysteine; Overdose

Indexed keywords

ALCOHOL; COTRIMOXAZOLE; CYCLOOXYGENASE 1; CYTOCHROME P450 2E1; GLUTATHIONE; HYPERICUM PERFORATUM EXTRACT; ISONIAZID; MYELOPEROXIDASE; N ACETYL 1,4 BENZOQUINONE IMINE; PARACETAMOL; PHENOBARBITAL; RIFAMPICIN; ZIDOVUDINE;

ACUTE LIVER FAILURE; AGING; ALCOHOL CONSUMPTION; CHRONIC LIVER DISEASE; DIAGNOSTIC PROCEDURE; DIET RESTRICTION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG GLUCURONIDATION; DRUG INTOXICATION; DRUG OXIDATION; GASTROINTESTINAL ABSORPTION; GENETIC POLYMORPHISM; GILBERT DISEASE; HERB DRUG INTERACTION; HUMAN; INCIDENCE; LIVER TOXICITY; LIVER TRANSPLANTATION; MALNUTRITION; MORTALITY; NOMOGRAM; NUTRITIONAL STATUS; PREGNANCY; RECOMMENDED DRUG DOSE; REVIEW; RISK FACTOR; TREATMENT DURATION; WASTE MANAGEMENT;

ACETAMINOPHEN; ACUTE LIVER FAILURE; DRUG-INDUCED LIVER INJURY; HEPATOTOXICITY; LIVER TRANSPLANTATION; N-ACETYLCYSTEINE; OVERDOSE;

ACETAMINOPHEN; ACETYLCYSTEINE; ANALGESICS, NON-NARCOTIC; ANTIPYRETICS; DRUG-INDUCED LIVER INJURY; HUMANS; LIVER FAILURE, ACUTE; RISK FACTORS;

EID: 84884912258     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2013.07.005     Document Type: Review

References (123)

1. Hodgman M.J., Garrard A.R. Areview of acetaminophen poisoning. Crit Care Clin 2012, 28(4):499-516.
2. Wysowski D.K., Governale L.A., Swann J. Trends in outpatient prescription drug use and related costs in the US: 1998-2003. Pharmacoeconomics 2006, 24(3):233-236.
3. Lee W.M. Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology 2004, 40(1):6-9.
4. Ostapowicz G., Fontana R.J., Schiodt F.V., et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002, 137(12):947-954.
5. Ayonrinde O.T., Phelps G.J., Hurley J.C., et al. Paracetamol overdose and hepatotoxicity at a regional Australian hospital: a 4-year experience. Intern Med J 2005, 35(11):655-660.
6. Cooper S.C., Aldridge R.C., Shah T., et al. Outcomes of liver transplantation for paracetamol (acetaminophen)-induced hepatic failure. Liver Transpl 2009, 15(10):1351-1357.
7. Reddy K.R., Schilsky M.L., Stravitz R., et al. Liver transplantation for acute liver failure: results from the NIH Acute Liver Failure Study Group. Hepatology 2012, 56(Suppl 4):246A-247A.
8. Larson A.M., Polson J., Fontana R.J., et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005, 42(6):1364-1372.
9. Zimmerman H.J., Maddrey W.C. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology 1995, 22(3):767-773.
10. Krenzelok E.P. The FDA Acetaminophen Advisory Committee Meeting: what is the future of acetaminophen in the United States? The perspective of a committee member. Clin Toxicol (Phila) 2009, 47(8):784-789.
11. Forrest J.A., Clements J.A., Prescott L.F. Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet 1982, 7(2):93-107.
12. Bizovi K.E., Aks S.E., Paloucek F., et al. Late increase in acetaminophen concentration after overdose of Tylenol Extended Relief. Ann Emerg Med 1996, 28(5):549-551.
13. Douglas D.R., Sholar J.B., Smilkstein M.J. Apharmacokinetic comparison of acetaminophen products (Tylenol Extended Relief vs regular Tylenol). Acad Emerg Med 1996, 3(8):740-744.
14. Schiodt F.V., Ott P., Christensen E., et al. The value of plasma acetaminophen half-life in antidote-treated acetaminophen overdosage. Clin Pharmacol Ther 2002, 71(4):221-225.
15. Larson A.M. Acetaminophen hepatotoxicity. Clin Liver Dis 2007, 11(3):525-548. vi.
16. Graham G.G., Scott K.F., Day R.O. Tolerability of paracetamol. Drug Saf 2005, 28(3):227-240.
17. Mitchell J.R., Jollow D.J., Potter W.Z., et al. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. JPharmacol Exp Ther 1973, 187(1):211-217.
18. Knight T.R., Fariss M.W., Farhood A., et al. Role of lipid peroxidation as a mechanism of liver injury after acetaminophen overdose in mice. Toxicol Sci 2003, 76(1):229-236.
19. McGill M.R., Sharpe M.R., Williams C.D., et al. The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. JClin Invest 2012, 122(4):1574-1583.
20. Jaeschke H., Williams C.D., Ramachandran A., et al. Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity. Liver Int 2012, 32(1):8-20.
21. Liu Z.X., Govindarajan S., Kaplowitz N. Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 2004, 127(6):1760-1774.
22. Dart R.C., Erdman A.R., Olson K.R., et al. Acetaminophen poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila) 2006, 44(1):1-18.
23. Temple A.R., Benson G.D., Zinsenheim J.R., et al. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis. Clin Ther 2006, 28(2):222-235.
24. Temple A.R., Lynch J.M., Vena J., et al. Aminotransferase activities in healthy subjects receiving three-day dosing of 4, 6, or 8 grams per day of acetaminophen. Clin Toxicol (Phila) 2007, 45(1):36-44.
25. Watkins P.B., Kaplowitz N., Slattery J.T., et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 2006, 296(1):87-93.
26. Lee W.M. Drug-induced hepatotoxicity. NEngl J Med 2003, 349(5):474-485.
27. Schmidt L.E., Dalhoff K., Poulsen H.E. Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity. Hepatology 2002, 35(4):876-882.
28. Waring W.S., Stephen A.F., Malkowska A.M., et al. Acute ethanol coingestion confers a lower risk of hepatotoxicity after deliberate acetaminophen overdose. Acad Emerg Med 2008, 15(1):54-58.
29. Lauterburg B.H., Velez M.E. Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity. Gut 1988, 29(9):1153-1157.
30. Zhao P., Slattery J.T. Effects of ethanol dose and ethanol withdrawal on rat liver mitochondrial glutathione: implication of potentiated acetaminophen toxicity in alcoholics. Drug Metab Dispos 2002, 30(12):1413-1417.
31. Thummel K.E., Slattery J.T., Ro H., et al. Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults. Clin Pharmacol Ther 2000, 67(6):591-599.
32. Schiodt F.V., Rochling F.A., Casey D.L., et al. Acetaminophen toxicity in an urban county hospital. NEngl J Med 1997, 337(16):1112-1117.
33. Dart R.C., Kuffner E.K., Rumack B.H. Treatment of pain or fever with paracetamol (acetaminophen) in the alcoholic patient: a systematic review. Am J Ther 2000, 7(2):123-134.
34. Kuffner E.K., Dart R.C., Bogdan G.M., et al. Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double-blind, placebo-controlled trial. Arch Intern Med 2001, 161(18):2247-2252.
35. Rumack B.H. Acetaminophen misconceptions. Hepatology 2004, 40(1):10-15.
36. Bray G.P., Harrison P.M., O'Grady J.G., et al. Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic failure. Hum Exp Toxicol 1992, 11(4):265-270.
37. Nolan C.M., Sandblom R.E., Thummel K.E., et al. Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis. Chest 1994, 105(2):408-411.
38. Bunchorntavakul C., Reddy K.R. Review article: herbal and dietary supplement hepatotoxicity. Aliment Pharmacol Ther 2013, 37(1):3-17.
39. Shriner K., Goetz M.B. Severe hepatotoxicity in a patient receiving both acetaminophen and zidovudine. Am J Med 1992, 93(1):94-96.
40. Critchley J.A., Nimmo G.R., Gregson C.A., et al. Inter-subject and ethnic differences in paracetamol metabolism. Br J Clin Pharmacol 1986, 22(6):649-657.
41. Ueshima Y., Tsutsumi M., Takase S., et al. Acetaminophen metabolism in patients with different cytochrome P-4502E1 genotypes. Alcohol Clin Exp Res 1996, 20(Suppl 1):25A-28A.
42. de Morais S.M., Uetrecht J.P., Wells P.G. Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome. Gastroenterology 1992, 102(2):577-586.
43. Miller R.P., Roberts R.J., Fischer L.J. Acetaminophen elimination kinetics in neonates, children, and adults. Clin Pharmacol Ther 1976, 19(3):284-294.
44. Rumore M.M., Blaiklock R.G. Influence of age-dependent pharmacokinetics and metabolism on acetaminophen hepatotoxicity. JPharm Sci 1992, 81(3):203-207.
45. Price V.F., Miller M.G., Jollow D.J. Mechanisms of fasting-induced potentiation of acetaminophen hepatotoxicity in the rat. Biochem Pharmacol 1987, 36(4):427-433.
46. Whitcomb D.C., Block G.D. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994, 272(23):1845-1850.
47. Zenger F., Russmann S., Junker E., et al. Decreased glutathione in patients with anorexia nervosa. Risk factor for toxic liver injury?. Eur J Clin Nutr 2004, 58(2):238-243.
48. Zapater P., Lasso de la Vega M.C., Horga J.F., et al. Pharmacokinetic variations of acetaminophen according to liver dysfunction and portal hypertension status. Aliment Pharmacol Ther 2004, 20(1):29-36.
49. Benson G.D., Koff R.S., Tolman K.G. The therapeutic use of acetaminophen in patients with liver disease. Am J Ther 2005, 12(2):133-141.
50. Riley T.R., Bhatti A.M. Preventive strategies in chronic liver disease. Part I. Alcohol, vaccines, toxic medications and supplements, diet and exercise. Am Fam Physician 2001, 64(9):1555-1560.
51. Chandok N., Watt K.D. Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin Proc 2010, 85(5):451-458.
52. Wilkes J.M., Clark L.E., Herrera J.L. Acetaminophen overdose in pregnancy. South Med J 2005, 98(11):1118-1122.
53. McElhatton P.R., Sullivan F.M., Volans G.N. Paracetamol overdose in pregnancy analysis of the outcomes of 300 cases referred to the Teratology Information Service. Reprod Toxicol 1997, 11(1):85-94.
54. Zyoud S.H., Awang R., Sulaiman S.A., et al. Assessing the impact of vomiting episodes on outcome after acetaminophen poisoning. Basic Clin Pharmacol Toxicol 2010, 107(5):887-892.
55. Singer A.J., Carracio T.R., Mofenson H.C. The temporal profile of increased transaminase levels in patients with acetaminophen-induced liver dysfunction. Ann Emerg Med 1995, 26(1):49-53.
56. Harrison P.M., O'Grady J.G., Keays R.T., et al. Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ 1990, 301(6758):964-966.
57. Shah A.D., Wood D.M., Dargan P.I. Understanding lactic acidosis in paracetamol (acetaminophen) poisoning. Br J Clin Pharmacol 2011, 71(1):20-28.
58. Blakely P., McDonald B.R. Acute renal failure due to acetaminophen ingestion: a case report and review of the literature. JAm Soc Nephrol 1995, 6(1):48-53.
59. Mazer M., Perrone J. Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management. JMed Toxicol 2008, 4(1):2-6.
60. Schmidt L.E., Dalhoff K. Hyperamylasaemia and acute pancreatitis in paracetamol poisoning. Aliment Pharmacol Ther 2004, 20(2):173-179.
61. Caldarola V., Hassett J.M., Hall A.H., et al. Hemorrhagic pancreatitis associated with acetaminophen overdose. Am J Gastroenterol 1986, 81(7):579-582.
62. Gyamlani G.G., Parikh C.R. Acetaminophen toxicity: suicidal vs. accidental. Crit Care 2002, 6(2):155-159.
63. Craig D.G., Bates C.M., Davidson J.S., et al. Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. Br J Clin Pharmacol 2012, 73(2):285-294.
64. Khandelwal N., James L.P., Sanders C., et al. Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. Hepatology 2011, 53(2):567-576.
65. Beuhler M.C., Curry S.C. False positive acetaminophen levels associated with hyperbilirubinemia. Clin Toxicol (Phila) 2005, 43(3):167-170.
66. Prescott L.F., Illingworth R.N., Critchley J.A., et al. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br Med J 1979, 2(6198):1097-1100.
67. Rumack B.H., Matthew H. Acetaminophen poisoning and toxicity. Pediatrics 1975, 55(6):871-876.
68. Rumack B.H., Peterson R.C., Koch G.G., et al. Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med 1981, 141(3Spec No):380-385.
69. Heard K.J. Acetylcysteine for acetaminophen poisoning. NEngl J Med 2008, 359(3):285-292.
70. Prescott L.F. Treatment of severe acetaminophen poisoning with intravenous acetylcysteine. Arch Intern Med 1981, 141(3 Spec No):386-389.
71. Prescott L.F. Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs 1983, 25(3):290-314.
72. Rumack B.H. Acetaminophen hepatotoxicity: the first 35 years. JToxicol Clin Toxicol 2002, 40(1):3-20.
73. Smilkstein M.J., Knapp G.L., Kulig K.W., et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). NEngl J Med 1988, 319(24):1557-1562.
74. Daly F.F., Fountain J.S., Murray L., et al. Guidelines for the management of paracetamol poisoning in Australia and New Zealand-explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. Med J Aust 2008, 188(5):296-301.
75. McQuade D.J., Dargan P.I., Keep J., et al. Paracetamol toxicity: what would be the implications of a change in UK treatment guidelines?. Eur J Clin Pharmacol 2012, 68(11):1541-1547.
76. Bond G.R., Hite L.K. Population-based incidence and outcome of acetaminophen poisoning by type of ingestion. Acad Emerg Med 1999, 6(11):1115-1120.
77. Bernal W., Wendon J., Rela M., et al. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology 1998, 27(4):1050-1055.
78. Makin A.J., Wendon J., Williams R. A7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology 1995, 109(6):1907-1916.
79. Stravitz R.T., Kramer A.H., Davern T., et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med 2007, 35(11):2498-2508.
80. Lee W.M. Acute liver failure. Semin Respir Crit Care Med 2012, 33(1):36-45.
81. Polson J., Lee W.M. AASLD position paper: the management of acute liver failure. Hepatology 2005, 41(5):1179-1197.
82. O'Grady J.G., Alexander G.J., Hayllar K.M., et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989, 97(2):439-445.
83. O'Grady J.G., Langley P.G., Isola L.M., et al. Coagulopathy of fulminant hepatic failure. Semin Liver Dis 1986, 6(2):159-163.
84. Craig D.G., Ford A.C., Hayes P.C., et al. Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther 2010, 31(10):1064-1076.
85. Lee W.M., Stravitz R.T., Larson A.M. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology 2012, 55(3):965-967.
86. Bailey B., Amre D.K., Gaudreault P. Fulminant hepatic failure secondary to acetaminophen poisoning: a systematic review and meta-analysis of prognostic criteria determining the need for liver transplantation. Crit Care Med 2003, 31(1):299-305.
87. Schmidt L.E., Larsen F.S. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology 2007, 45(3):789-796.
88. Cholongitas E., Theocharidou E., Vasianopoulou P., et al. Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure. Liver Transpl 2012, 18(4):405-412.
89. Craig D.G., Reid T.W., Wright E.C., et al. The sequential organ failure assessment (SOFA) score is prognostically superior to the model for end-stage liver disease (MELD) and MELD variants following paracetamol (acetaminophen) overdose. Aliment Pharmacol Ther 2012, 35(6):705-713.
90. Craig D.G., Zafar S., Reid T.W., et al. The sequential organ failure assessment (SOFA) score is an effective triage marker following staggered paracetamol (acetaminophen) overdose. Aliment Pharmacol Ther 2012, 35(12):1408-1415.
91. Mitchell I., Bihari D., Chang R., et al. Earlier identification of patients at risk from acetaminophen-induced acute liver failure. Crit Care Med 1998, 26(2):279-284.
92. James L.P., Letzig L., Simpson P.M., et al. Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure. Drug Metab Dispos 2009, 37(8):1779-1784.
93. Davern T.J., James L.P., Hinson J.A., et al. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology 2006, 130(3):687-694.
94. Spiller H.A., Krenzelok E.P., Grande G.A., et al. Aprospective evaluation of the effect of activated charcoal before oral N-acetylcysteine in acetaminophen overdose. Ann Emerg Med 1994, 23(3):519-523.
95. Spiller H.A., Winter M.L., Klein-Schwartz W., et al. Efficacy of activated charcoal administered more than four hours after acetaminophen overdose. JEmerg Med 2006, 30(1):1-5.
96. Underhill T.J., Greene M.K., Dove A.F. Acomparison of the efficacy of gastric lavage, ipecacuanha and activated charcoal in the emergency management of paracetamol overdose. Arch Emerg Med 1990, 7(3):148-154.
97. Christophersen A.B., Levin D., Hoegberg L.C., et al. Activated charcoal alone or after gastric lavage: a simulated large paracetamol intoxication. Br J Clin Pharmacol 2002, 53(3):312-317.
98. Lin J.H., Levy G. Sulfate depletion after acetaminophen administration and replenishment by infusion of sodium sulfate or N-acetylcysteine in rats. Biochem Pharmacol 1981, 30(19):2723-2725.
99. Lauterburg B.H., Corcoran G.B., Mitchell J.R. Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats invivo. JClin Invest 1983, 71(4):980-991.
100. Brok J., Buckley N., Gluud C. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database Syst Rev 2006, (2). CD003328.
101. Prescott L.F., Park J., Ballantyne A., et al. Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet 1977, 2(8035):432-434.
102. Harrison P.M., Keays R., Bray G.P., et al. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 1990, 335(8705):1572-1573.
103. Keays R., Harrison P.M., Wendon J.A., et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ 1991, 303(6809):1026-1029.
104. Lee W.M., Hynan L.S., Rossaro L., et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009, 137(3):856-864. 864.e1.
105. Varney S.M., Buchanan J.A., Kokko J., et al. Acetylcysteine for acetaminophen overdose in patients who weigh>100 kg. Am J Ther 2012, [Epub ahead of print].
106. Kanter M.Z. Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning. Am J Health Syst Pharm 2006, 63(19):1821-1827.
107. Dawson A.H., Henry D.A., McEwen J. Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning. Med J Aust 1989, 150(6):329-331.
108. Kerr F., Dawson A., Whyte I.M., et al. The Australasian Clinical Toxicology Investigators Collaboration randomized trial of different loading infusion rates of N-acetylcysteine. Ann Emerg Med 2005, 45(4):402-408.
109. Bailey B., McGuigan M.A. Management of anaphylactoid reactions to intravenous N-acetylcysteine. Ann Emerg Med 1998, 31(6):710-715.
110. Betten D.P., Burner E.E., Thomas S.C., et al. Aretrospective evaluation of shortened-duration oral N-acetylcysteine for the treatment of acetaminophen poisoning. JMed Toxicol 2009, 5(4):183-190.
111. Betten D.P., Cantrell F.L., Thomas S.C., et al. Aprospective evaluation of shortened course oral N-acetylcysteine for the treatment of acute acetaminophen poisoning. Ann Emerg Med 2007, 50(3):272-279.
112. Woo O.F., Mueller P.D., Olson K.R., et al. Shorter duration of oral N-acetylcysteine therapy for acute acetaminophen overdose. Ann Emerg Med 2000, 35(4):363-368.
113. Yip L., Dart R.C. A20-hour treatment for acute acetaminophen overdose. NEngl J Med 2003, 348(24):2471-2472.
114. Tsai C.L., Chang W.T., Weng T.I., et al. Apatient-tailored N-acetylcysteine protocol for acute acetaminophen intoxication. Clin Ther 2005, 27(3):336-341.
115. Smilkstein M.J., Bronstein A.C., Linden C., et al. Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med 1991, 20(10):1058-1063.
116. Fontana R.J. Acute liver failure including acetaminophen overdose. Med Clin North Am 2008, 92(4):761-794. viii.
117. Speeg K.V., Mitchell M.C., Maldonado A.L. Additive protection of cimetidine and N-acetylcysteine treatment against acetaminophen-induced hepatic necrosis in the rat. JPharmacol Exp Ther 1985, 234(3):550-554.
118. Burkhart K.K., Janco N., Kulig K.W., et al. Cimetidine as adjunctive treatment for acetaminophen overdose. Hum Exp Toxicol 1995, 14(3):299-304.
119. Slattery J.T., McRorie T.I., Reynolds R., et al. Lack of effect of cimetidine on acetaminophen disposition in humans. Clin Pharmacol Ther 1989, 46(5):591-597.
120. Kaplowitz N. Acetaminophen hepatoxicity: what do we know, what don't we know, and what do we do next?. Hepatology 2004, 40(1):23-26.
121. Scheiermann P., Bachmann M., Goren I., et al. Application of interleukin-22 mediates protection in experimental acetaminophen-induced acute liver injury. Am J Pathol 2013, 182(4):1107-1113.
122. Fouad A.A., Al-Mulhim A.S., Jresat I., et al. Therapeutic role of telmisartan against acetaminophen hepatotoxicity in mice. Eur J Pharmacol 2012, 693(1-3):64-71.
123. Fouad A.A., Jresat I. Hepatoprotective effect of coenzyme Q10 in rats with acetaminophen toxicity. Environ Toxicol Pharmacol 2012, 33(2):158-167.